Histone H2A type 3, Human

The family of histone H2A proved that there are a lot of variants associated with cancer development. HIST3H2A is a promising biomarker for predicting prognosis of pancreatic cancer, and it could be a potential therapeutic target. HIST3H2A might regulate the progression of tumor immune in pancreatic cancer through modulating the JAK-STAT pathway. In addition, the role HIST3H2A in pancreatic cancer may be related to DCST1-AS1, HIST1H2B, SLC12A9-AS1.

Price	$390.00
Cat. No.	Z05379-100
Size	100 μg 500 μg Buy in bulk
Quantity
Est. Delivery


Ask us a question

Product Introduction Background Bottom Notes

Product Introduction

Species

Human

Protein Construction

Histone H2A type 3 (Ser2-Lys130)
Accession # Q7L7L0

Purity

> 95% as determined by Bis-Tris PAGE

Endotoxin Level

Less than 1EU per μg by the LAL method.

Expression System

E.coli

Theoretical Molecular Weight

13.99 kDa

Apparent Molecular Weight

The protein migrates to 15-20 kDa based on Bis-Tris PAGE result.

Formulation

Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4).

Reconstitution

Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water.

Storage & Stability

Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles.

Back

Histone H2A type 3, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »

Background

Target Background

Synonyms

H2AC25; H2AW; HIST3H2A

Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.